Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis
Prelamin A undergoes multistep processing to yield lamin A, a structural protein of the nuclear lamina. Prelamin A terminates with a CAAX motif, which triggers farnesylation of a C-terminal cysteine (the C of the CAAX motif), endoproteolytic release of the last three amino acids (the AAX), and methy...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-12-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S002222752032842X |
_version_ | 1818731723144298496 |
---|---|
author | Stephen G. Young Loren G. Fong Susan Michaelis |
author_facet | Stephen G. Young Loren G. Fong Susan Michaelis |
author_sort | Stephen G. Young |
collection | DOAJ |
description | Prelamin A undergoes multistep processing to yield lamin A, a structural protein of the nuclear lamina. Prelamin A terminates with a CAAX motif, which triggers farnesylation of a C-terminal cysteine (the C of the CAAX motif), endoproteolytic release of the last three amino acids (the AAX), and methylation of the newly exposed farnesylcysteine residue. In addition, prelamin A is cleaved a second time, releasing 15 more residues from the C terminus (including the farnesylcysteine methyl ester), generating mature lamin A. This second cleavage step is carried out by an endoplasmic reticulum membrane protease, ZMPSTE24. Interest in the posttranslational processing of prelamin A has increased with the recognition that certain progeroid syndromes can be caused by mutations that lead to an accumulation of farnesyl-prelamin A. Recently, we showed that a key cellular phenotype of these progeroid disorders, misshapen cell nuclei, can be ameliorated by inhibitors of protein farnesylation, suggesting a potential strategy for treating these diseases.In this article, we review the posttranslational processing of prelamin A, describe several mouse models for progeroid syndromes, explain the mutations underlying several human progeroid syndromes, and summarize recent data showing that misshapen nuclei can be ameliorated by treating cells with protein farnesyltransferase inhibitors. |
first_indexed | 2024-12-17T23:22:12Z |
format | Article |
id | doaj.art-3f0757fc37fe497cb77bf7a65fd3bc23 |
institution | Directory Open Access Journal |
issn | 0022-2275 |
language | English |
last_indexed | 2024-12-17T23:22:12Z |
publishDate | 2005-12-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Lipid Research |
spelling | doaj.art-3f0757fc37fe497cb77bf7a65fd3bc232022-12-21T21:28:51ZengElsevierJournal of Lipid Research0022-22752005-12-01461225312558Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesisStephen G. Young0Loren G. Fong1Susan Michaelis2To whom correspondence should be addressed.; Division of Cardiology, Department of Internal Medicine, University of California, Los Angeles, CA 90095Division of Cardiology, Department of Internal Medicine, University of California, Los Angeles, CA 90095To whom correspondence should be addressed.; Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205Prelamin A undergoes multistep processing to yield lamin A, a structural protein of the nuclear lamina. Prelamin A terminates with a CAAX motif, which triggers farnesylation of a C-terminal cysteine (the C of the CAAX motif), endoproteolytic release of the last three amino acids (the AAX), and methylation of the newly exposed farnesylcysteine residue. In addition, prelamin A is cleaved a second time, releasing 15 more residues from the C terminus (including the farnesylcysteine methyl ester), generating mature lamin A. This second cleavage step is carried out by an endoplasmic reticulum membrane protease, ZMPSTE24. Interest in the posttranslational processing of prelamin A has increased with the recognition that certain progeroid syndromes can be caused by mutations that lead to an accumulation of farnesyl-prelamin A. Recently, we showed that a key cellular phenotype of these progeroid disorders, misshapen cell nuclei, can be ameliorated by inhibitors of protein farnesylation, suggesting a potential strategy for treating these diseases.In this article, we review the posttranslational processing of prelamin A, describe several mouse models for progeroid syndromes, explain the mutations underlying several human progeroid syndromes, and summarize recent data showing that misshapen nuclei can be ameliorated by treating cells with protein farnesyltransferase inhibitors.http://www.sciencedirect.com/science/article/pii/S002222752032842Xprotein prenylationlaminopathyagingSte24a-factorlamin A/C |
spellingShingle | Stephen G. Young Loren G. Fong Susan Michaelis Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis Journal of Lipid Research protein prenylation laminopathy aging Ste24 a-factor lamin A/C |
title | Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis |
title_full | Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis |
title_fullStr | Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis |
title_full_unstemmed | Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis |
title_short | Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis |
title_sort | thematic review series lipid posttranslational modifications prelamin a zmpste24 misshapen cell nuclei and progeria new evidence suggesting that protein farnesylation could be important for disease pathogenesis |
topic | protein prenylation laminopathy aging Ste24 a-factor lamin A/C |
url | http://www.sciencedirect.com/science/article/pii/S002222752032842X |
work_keys_str_mv | AT stephengyoung thematicreviewserieslipidposttranslationalmodificationsprelaminazmpste24misshapencellnucleiandprogerianewevidencesuggestingthatproteinfarnesylationcouldbeimportantfordiseasepathogenesis AT lorengfong thematicreviewserieslipidposttranslationalmodificationsprelaminazmpste24misshapencellnucleiandprogerianewevidencesuggestingthatproteinfarnesylationcouldbeimportantfordiseasepathogenesis AT susanmichaelis thematicreviewserieslipidposttranslationalmodificationsprelaminazmpste24misshapencellnucleiandprogerianewevidencesuggestingthatproteinfarnesylationcouldbeimportantfordiseasepathogenesis |